MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$7,375K
Free Cash flow
-$5,047K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Depreciation and amortization
Sale of short-term marketable se...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Net loss
Other acquisitions, including cl...
Accrued expenses and other liabi...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-10,687
-10,103
-11,773
-17,772
Goodwill and other intangible asset impairments
-
2,349
4,163
-
Depreciation and amortization
5,721
5,602
5,299
10,218
Loss on early extinguishment of debt
-
0
0
-
Stock-based compensation
3,982
4,416
4,251
9,111
Fair value adjustment of contingent consideration
-
0
-
-
Accretion of acquisition installment payable
72
-16
7
98
Deferred income taxes
-314
-273
-125
245
Non-cash other
50
332
12
-100
Accounts receivable - trade
183
1,096
-3,111
11,381
Inventories
-139
576
-1,006
8,899
Prepaid expenses and other current assets
483
-238
-677
501
Accounts payable - trade
704
10,128
-5,681
3,720
Accrued expenses and other liabilities
-3,571
458
-1,719
2,509
Other
-1,283
1,111
-191
1,866
Net cash used in operating activities
-3,287
10,348
-581
-14,618
Acquisition of boston o&p, net of cash acquired
-
0
0
0
Other acquisitions, including clinics, net of cash acquired
6,777
6,650
8,532
320
Acquisition of medtech, net of cash acquired
-
-2,007
467
1,540
Acquisition of rhino assets
-
0
-
-
Sale of short-term marketable securities
5,000
0
0
0
Purchase of short-term marketable securities
-
0
15,000
-
Investment in private companies and purchases of licenses
250
2,017
-
-
Purchases of property and equipment
1,760
599
2,839
7,672
Net cash used in investing activities
-3,787
-7,259
-26,838
-9,532
Proceeds from issuance of debt
-
0
0
25,000
Payment of debt issuance costs
-
0
0
0
Installment payments-Clinic Acquisitions
-
378
241
248
Payment on debt
-
0
0
-
Proceeds from exercise of stock options
-
0
-
-
Installment payments-Api Fix Ltd
-
0
0
0
Installment payments-Medtech
-
0
0
0
Payments on mortgage notes
41
39
41
78
Payments on acquisition notes
573
-
-
-
Net cash used in financing activities
-614
-417
-282
24,674
Effect of exchange rate changes on cash, cash equivalents and restricted cash
313
64
-20
304
Net decrease in cash, cash equivalents and restricted cash
-7,375
2,736
-27,721
828
Cash, cash equivalents and restricted cash, beginning of year
21,620
18,884
45,777
-
Cash, cash equivalents and restricted cash, end of period
14,245
21,620
18,884
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Effect of exchange rate
changes on cash, cash...
$313K
Net decrease in
cash, cash...
-$7,375K
Canceled cashflow
$313K
Sale of short-term
marketable securities
$5,000K
Depreciation and
amortization
$5,721K
Stock-based compensation
$3,982K
Other
-$1,283K
Accounts payable - trade
$704K
Inventories
-$139K
Accretion of acquisition
installment payable
$72K
Non-cash other
$50K
Net cash used in
investing activities
-$3,787K
Net cash used in
operating activities
-$3,287K
Net cash used in
financing activities
-$614K
Canceled cashflow
$5,000K
Canceled cashflow
$11,951K
Other acquisitions,
including clinics, net of...
$6,777K
Net loss
-$10,687K
Payments on acquisition
notes
$573K
Payments on mortgage
notes
$41K
Purchases of property and
equipment
$1,760K
Investment in private
companies and purchases of...
$250K
Accrued expenses and
other liabilities
-$3,571K
Prepaid expenses and
other current assets
$483K
Deferred income taxes
-$314K
Accounts receivable -
trade
$183K
Buy us a coffee
ORTHOPEDIATRICS CORP (KIDS)
ORTHOPEDIATRICS CORP (KIDS)